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Dr Frank Arko (Dallas, Tex). Dr Deaton and coauthors
discuss the early results of the phase I multicenter trial of the Aptus
Endovascular Repair System. I congratulate the authors and the
manufacturers for completing this initial phase. I have several
questions for the authors.
Dr. Deaton, how many EndoStaples are actually necessary for
each case to get a satisfactory outcome? What is the pull-out force
for a staple in tissue as compared to a silicone model?
What is the learning curve on using these EndoStaples? I am
the US principal investigator for a competitive endostapling device
that’s able to be used with any Dacron stent graft and I believe
there is a learning curve to using these devices and I’d like to get
your thoughts on what it is with this device.
Next, please comment on neck calcification, thrombus, angu-
lation, and short neck length on the ability to accurately implant
your EndoStaple and are any of these factors contraindications to
using this endograft?
And then finally, with five currently approved devices within
the United States, all of which have excellent 5-year results, can
you elaborate on what you believe this repair system adds to the
current treatment options?
Dr Deaton. The number of staples required in the phase I
study was 2 but 4 was the number generally recommended and was
the median number in the study. Only 1 patient received 2 staples
and 1 patient had as many as 10. When more than 4 staples were
applied, it was usually to address sealing issues. Fundamentally, the
intention is to give the operator control over how many staples are
needed in their clinical judgment.
While there is undoubtedly a learning curve, the controlled
nature of this helical staple deployment provided for early success
and no misdeployed staples throughout this initial experience. The
positioning of the EndoGuide against the aortic wall followed by
an electronically controlled and staged staple deployment made
the initial learning curve for users fairly shallow.
With respect to the ability of the staple to penetrate aortic
pathology, we don’t have any evidence of staples that did not
penetrate the tissue they were intended to penetrate. That being
said, excessive calcification in the aortic neck is excluded in the trial.
While there is ex vivo evidence of staple penetration through
calcified aortic plaque, we will probably not understand the limi-
tations of this helical staple until we have a much broader experi-
ence in less restricted clinical applications.
With respect to the pullout force, there is early work being
done in a tissue model that I think will back up the numbers
attained in an artificial silastic model. What is fundamentally differ-
ent from most other endograft technologies is that the degree of
fixation achieved by these staples appears to be related to the tissue
into which they are implanted rather than the mechanical integrity
of the staple itself. That is to say that what gives way is the tissue
rather than the structure of the staple. So if it is weak tissue it will
not achieve those high levels of pull-out force just as sutures in
open surgery will tear through tissues with poor integrity. Another
essential aspect of this type of fixation is that it is easily visualized on
postoperative plain x-ray so we will be able to follow any compro-
mise to the staple or any evidence of change in position of a
particular staple.Dr Arko. I think you got most of them. The last one is – and
I’m going to add a little more to it since you made me stand up
here – what do you think the advantages of this endograft is over
other endografts?
And I’d like to ask you if you could describe the actual stent
graft in somemore detail including the distance from the top of the
graft to the flow divider. I have found that with the shorter bodied
stent grafts that it’s actually a bit more difficult to implant the
staples because I lose some ability to guide the catheter and in the
shorter bodied stent grafts I have found it easier to go up both sides
to implant the endostaples. Whereas with a longer bodied stent
graft, I can really get the staples in from either side. Can you
comment on that?
Dr Deaton. With respect to the staple implantation, on rare
occasions we have used both limbs to implant staples, but in over
90% of the cases it is easy to implant staples circumferentially from
one side. The main body in this study was 4 cm long. In the phase
II study, there were 4, 5, and 6 cm body lengths to give the
operator better sizing capabilities and to add flexibility to planning
for unusual anatomic configurations. As for the body length inhib-
iting stapling, we have not seen that. The EndoGuide was specifi-
cally designed to work in the 4 cm length body and the unsup-
ported nature of the main body also allows more flexibility in staple
positioning and deployment.
One of the primary advantages of this endograft system is the
possibility of achieving a degree of proximal fixation on a par with
a hand-sewn anastomosis. If that proves to be the case, wemay well
be able to document a treatment paradigm that does not involve
the lengthy and potentially dangerous necessity of annual CT
scans. Another key advantage of a helical staple is the possibility of
preventing future neck dilatation as the “bidirectional” nature of
helical staple fixation should hold the aorta to the graft rather than
just holding the graft up against the aortic wall. The separation of
the fixation delivery from the graft delivery allows an entirely new
approach to endograft design that maintains a very high degree of
graft structural integrity while bringing the graft delivery catheter
caliber down to 16F. There are a variety of other more nuanced
features made possible by the design of the endograft that we are
still learning about, the most prominent being the non-stented
main body and the ability to treat angulated necks, facilitate
contralateral cannulation, etc. Beyond the scope of this particular
technology, I think any independent fixation technology will allow
an entirely new approach to endograft design that will give the
operator the ability to treat a broader group of patients more
effectively with better long-term results.
Dr Wayne Zhang (Loma Linda, Calif). You use staples for
proximal fixation. Do you have any migration after deployment of
the stent graft before you put staples?
The second question is are you worried about bleeding? Can
the staples cause penetration and bleeding? Do you need to do a
CT scan immediately after the procedure?
And another question is, when you deploy the staples, if you
have an angled neck, how do you position?
Dr Deaton. We don’t see any bleeding from implanting the
staples. We haven’t seen it in an animal model. And it really is the
helical nature of it is much less than what you would do in open
surgery.
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straight across that proximal stent, because that is where we like to
implant the staples.
And your first question again was?
Dr Zhang. Do you have any migration after deployment of
the stent graft before you put staples?
Dr Deaton. Can you move the graft? It can move, but that
proximal sealing stent has a fairly high radial force so it’s done with
some difficulty. But before you do that, when you uncover the
entire graft, it’s easily mobile at that point.
DrWesleyMoore (Los Angeles, Calif). Does the device go up
bare or are you putting it in through a sheath?
How far beyond the outer wall of the aorta does the staple go?
Do you have any concern about puncturing the left renal vein or
the cava when you put the staple in place?
Dr Deaton. As far as the staple penetration, it’s 4 mm and it’s
designed to basically just go through the aortic wall. We’ve not
seen any complications related to it. And I’ve neglected to show
you a slide, but it’s very different, when you penetrate a vessel with
a barb, you have a barb sticking through the aorta. This helical
screw has a much lower profile. It doesn’t have something sticking
up like a nail, if you will.
Dr Moore. Does this go bare or through a sheath?
Dr Deaton. It’s designed to go bareback and it can. If they
have adequate iliac access vessels, we do place a sheath just to
facilitate exchanges and intraoperative imaging but there is no
reason you have to place a sheath. The delivery system, as you can
see, is tapered and we generally re-jacket the entire delivery system
on removing it to prevent any iliac trauma.
DrMoore. Finally, in one of the patients you mentioned that
you placed one or two cuffs proximally. Was that because the graft
moved before you had a chance to staple it, or did you staple it and
had to place cuffs in addition to that?
Dr Deaton. It wasn’t because the graft moved, but I think it
was because of some irregularity in the neck that the short stentdidn’t fulfill the sealing requirements and so we added support to
the main body to lengthen the sealing zone. In the phase II study,
which is underway now, an aortic cuff designed specifically for this
unique endograft system has been added to the portfolio of the
system. This allows operators the ability to provide for a longer
sealing zone in the main body with the fully-stented aortic cuff
positioned within the main body or to extend the length of the
main body cephalad when a more distal area is deemed more
appropriate for staple implantation.
Dr Jean Panneton (Norfolk, Va). As a co-investigator in the
Aptus trial, I can tell you all that it’s actually a very slick device. I
think the delivery is very intuitive which, as surgeons, we like. I
think the learning curve for the EndoStapler is actually pretty
short. I think it’s also very intuitive to use and very user friendly.
One potential improvement would be shortening the radius of
the EndoStapler, especially when there is angulation of the aneu-
rysm neck; I think it would help the stapling.
My concern is the limb occlusion rate. I’m sure you have that
same concern. I think you might explain this as technical difficul-
ties or maybe from the iliac anatomy, but do you think there is a
need to change the graft to try to prevent this problem? Is it
because it is so flexible and does not have columnar strength that
it’s going to be more likely to kink or occlude in tortuous iliacs?
Dr Deaton. We’ve had 2 patients with limb occlusions and 1
of those was diagnosed with a severe hypercoagulability condition
postoperatively. The other patient with a limb occlusion was likely
the result of deploying the limb too low in the docking zone
resulting in an unsupported proximal limb that happened to be at
an angulated portion of the aorta where the neck terminated into
the aneurysm sac. Having said that, there have been several design
changes in the endograft system being used in the phase II to
provide for better adaptation to tortuosity such that even acute
bends of 90° can be accommodated by the graft limbs without
luminal compromise.
